Analysis of the Kaplan–Meier plotter revealed that the level of TRPM2 was associated with OS in KIRC, PAAD, and BLCA patients based on the enrichment of different immune cells. The gene discussed is TRPM2; the disease is bladder transitional cell carcinoma.